Skip to Main Content

Paper Details

Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.
Blood
48
2021
-, /, ABL1, AFF1, B-ALL, B-lineage acute lymphoblastic leukemia, BCL2, BCR, DUX4, ETV6, IKZF1, KMT2A, MEF2D, MYC, P80R, PAX5, PAX5 P80R, PAX5alt, PBX1, Ph, RUNX1/-like, TCF3, TP53, TP53 mutations, ZNF384, ZNF384-R, ZNF384/-, low, near, patient, patients, pediatric, white blood cell
Author NameAffiliation
Kathryn G RobertsSt Jude Children's Research Hospital
Victoria WangDana-Farber Cancer Institute
Cheng ChengSt. Jude Children's Research Hospital
Chunxu QuSt Jude Children's Research Hospital
Stanley PoundsSt. Jude Children's Research Hospital
Stanley PoundsSt. Jude Children's Research Hospital
Ari MelnickWeill Medical College of Cornell University
Anthony V MoormanNewcastle University Translational and Clinical Research Institute
Martin S TallmanMemorial Sloan Kettering Cancer Center, Weill Cornell Medical College
Charles G MullighanSt Jude Children's Research Hospital
  • 1 - 10

Datasets

Release 1.2